CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- DEF 14C Other DEF 14C
- PRE 14C Other PRE 14C
- D Other Notice of Sales of Unregistered Securities
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-12B/A Other 10-12B/A
- CERTNYS Other Certification by the New York Stock Exchange
- 10-12B/A Other 10-12B/A
- RW Other RW
- 10-12B Other 10-12B
- D Other Notice of Sales of Unregistered Securities
- 10-12G Other 10-12G
- D Other Notice of Sales of Unregistered Securities
Page 3 of 3 · 59 filings